Subtype
Intracranial Neoplasm
CI-CAN-00001030Explore in graph →
Non-malignant522 active trials34 evidence items
- NCIt
- C4953
Loading cancer entity…
Loading cancer entity…
Subtype
CI-CAN-00001030Explore in graph →
Clinical trials
2,178 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT00565903 | Elucidating the Genetic Basis of the Pleuropulmonary Blastoma (PPB) Familial Cancer Syndrome(PPB) | completed | — | 1,247 | Ashley HillOTHER | 1 | Mar 1, 2023 | clinicaltrials |
| NCT03250520 | Application of Palliative Treatment in Children With Brain Stem Glioma and Recurrent High-grade Tumors in the Central Nervous System With the Nanomaterial NPt-Ca | completed | Early Phase 1 | 8 | Hospital Infantil de Mexico Federico GomezOTHER | 1 |
| Feb 28, 2023 |
| clinicaltrials |
| NCT04334863 | WP1066 in Children With Refractory and Progressive or Recurrent Malignant Brain Tumors | completed | Phase 1 | 10 | Emory UniversityOTHER | 1 | Feb 21, 2023 | clinicaltrials |
| NCT03273712 | Dosimetry-Guided, Peptide Receptor Radiotherapy (PRRT) With 90Y-DOTA- tyr3-Octreotide (90Y-DOTATOC) | completed | Phase 2 | 39 | University of IowaOTHER | 1 | Feb 9, 2023 | clinicaltrials |
| NCT05717335 | Observational Pilot Study With TachoSil as a Ventricular Sealant | completed | — | 20 | Germans Trias i Pujol HospitalOTHER | 1 | Feb 8, 2023 | clinicaltrials |
| NCT05103735 | Propofol-remifentanyl Versus Dexmedetomidine in Awake Craniotomy: Impact on Electroclinical Seizure Activity | completed | — | 170 | Azienda Sanitaria-Universitaria Integrata di UdineOTHER | 1 | Jan 31, 2023 | clinicaltrials |
| NCT04170777 | Perfexion Registration Using CBCT | completed | — | 1,250 | University Health Network, TorontoOTHER | 1 | Jan 26, 2023 | clinicaltrials |
| NCT03072134 | Neural Stem Cell Based Virotherapy of Newly Diagnosed Malignant Glioma | completed | Phase 1 | 12 | Northwestern UniversityOTHER | 1 | Jan 20, 2023 | clinicaltrials |
| NCT04075370 | Exploring Compensation to Maintain Cognitive Function in Adults Newly Diagnosed With Brain Cancer | completed | — | 33 | Duke UniversityOTHER | 1 | Jan 20, 2023 | clinicaltrials |
| NCT04584827 | Evaluation of Lactate in Patients Undergoing Glial and Non Glial Mass Surgery With Craniotomy | completed | — | 100 | Trakya UniversityOTHER | 1 | Jan 19, 2023 | clinicaltrials |
| NCT03888014 | Intraoperative Fluorescence With Augmented Reality | completed | — | 7 | Cedars-Sinai Medical CenterOTHER | 1 | Jan 18, 2023 | clinicaltrials |
| NCT04430842 | Dose Escalation Study to Assess the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of QBS10072S | completed | Phase 1 | 15 | Quadriga Biosciences, Inc.INDUSTRY | 1 | Jan 18, 2023 | clinicaltrials |
| NCT04657315 | Evaluation of Maximum Tolerated Dose, Safety and Efficiency of MSC11FCD Therapy to Recurrent Glioblastoma Patients(MSC11FCD-GBM) | completed | Phase 1 / Phase 2 | 10 | CHA UniversityOTHER | 1 | Jan 18, 2023 | clinicaltrials |
| NCT03355794 | A Study of Ribociclib and Everolimus Following Radiation Therapy in Children With Newly Diagnosed Non-biopsied Diffuse Pontine Gliomas (DIPG) and RB+ Biopsied DIPG and High Grade Gliomas (HGG) | completed | Phase 1 | 19 | Children's Hospital Medical Center, CincinnatiOTHER | 1 | Jan 13, 2023 | clinicaltrials |
| NCT02311920 | Ipilimumab and/or Nivolumab in Combination With Temozolomide in Treating Patients With Newly Diagnosed Glioblastoma or Gliosarcoma | completed | Phase 1 | 32 | National Cancer Institute (NCI)NIH | 1 | Jan 10, 2023 | clinicaltrials |
| NCT02017964 | Combination Chemotherapy in Treating Younger Patients With Newly Diagnosed, Non-metastatic Desmoplastic Medulloblastoma | completed | Phase 2 | 26 | Children's Oncology GroupNETWORK | 4 | Jan 9, 2023 | clinicaltrials |
| NCT00312728 | A Study of Bevacizumab in Combination With First- or Second-Line Therapy in Subjects With Treated Brain Metastases Due to Non-Squamous NSCLC (PASSPORT) | completed | Phase 2 | 115 | Genentech, Inc.INDUSTRY | 0 | Jan 6, 2023 | clinicaltrials |
| NCT01730950 | Bevacizumab With or Without Radiation Therapy in Treating Patients With Recurrent Glioblastoma | completed | Phase 2 | 182 | Radiation Therapy Oncology GroupNETWORK | 1 | Dec 29, 2022 | clinicaltrials |
| NCT01974804 | Assessment of Early Treatment Response by Diffusion and Perfusion MRI in Patients With Brain Metastasis | completed | — | 30 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Dec 29, 2022 | clinicaltrials |
| NCT02849171 | Assessing 11C-Choline (11C-CH) PET to Distinguish True Tumor Progression From Pseudoprogression in High-grade Gliomas | completed | N/A | 8 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Dec 29, 2022 | clinicaltrials |
| NCT02037945 | 18F-Fluorocholine (18F-FCho) to Distinguish Necrosis From Recurrence in Brain Metastases | completed | N/A | 19 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Dec 19, 2022 | clinicaltrials |
| NCT04782596 | Transnasal Endoscopic Pituitary Surgery - the Effect of Posterior Nasal Septum Resection on Nasal Functions | completed | N/A | 30 | University Hospital OstravaOTHER | 1 | Dec 7, 2022 | clinicaltrials |
| NCT04132843 | Novel MRI Techniques for the Characterization and Treatment Assessment of High Grade Brain Lesions | completed | N/A | 6 | M.D. Anderson Cancer CenterOTHER | 1 | Nov 21, 2022 | clinicaltrials |
| NCT04597801 | Comparison of Fluorescein-INtra-VItal Microscopy Versus Conventional Frozen Section Diagnosis for intraOperative Histopathological Evaluation(INVIVO) | completed | Phase 2 | 210 | Technical University of MunichOTHER | 1 | Nov 10, 2022 | clinicaltrials |
| NCT02115139 | GEM STUDY: Radiation And Yervoy in Patients With Melanoma and Brain Metastases(GRAY-B) | completed | Phase 2 | 58 | Grupo Español Multidisciplinar de MelanomaOTHER | 1 | Nov 8, 2022 | clinicaltrials |
| NCT03668847 | DM-CHOC-PEN for Brain Tumors in AYA Subjects | completed | Phase 2 | 20 | DEKK-TEC, Inc.INDUSTRY | 1 | Nov 8, 2022 | clinicaltrials |
| NCT04860934 | Dual Task Training On Children With Ataxia After Medulloblastoma Resection | completed | N/A | 30 | Children's Cancer Hospital Egypt 57357OTHER | 1 | Nov 8, 2022 | clinicaltrials |
| NCT02274987 | Molecular Profiling for Individualized Treatment Plan for DIPG | completed | N/A | 38 | University of California, San FranciscoOTHER | 1 | Nov 4, 2022 | clinicaltrials |
| NCT03666507 | Vegetative Monitoring During Brainstem-associated Surgery | completed | — | 103 | University Hospital TuebingenOTHER | 1 | Nov 4, 2022 | clinicaltrials |
| NCT04114786 | 3D Printed Mask for GBM and Brain Mets | completed | N/A | 40 | University Health Network, TorontoOTHER | 1 | Oct 21, 2022 | clinicaltrials |
| NCT01469247 | Diffuse Intrinsic Pontine Glioma (DIPG) Reirradiation (ReRT) | completed | Phase 1 / Phase 2 | 12 | M.D. Anderson Cancer CenterOTHER | 1 | Oct 20, 2022 | clinicaltrials |
| NCT00981890 | Stereotactic Radiosurgery With Sunitinib for Brain Metastases | completed | Phase 1 | 22 | University Health Network, TorontoOTHER | 1 | Oct 7, 2022 | clinicaltrials |
| NCT02849743 | Intranasal Oxytocin in Hypothalamic Obesity | completed | Phase 2 | 18 | Shana McCormack, MDOTHER | 1 | Oct 5, 2022 | clinicaltrials |
| NCT01621906 | 18F-FLT-PET Imaging of the Brain in Patients With Metastatic Breast Cancer to the Brain Treated With Whole Brain Radiation Therapy With or Without Sorafenib: Comparison With MR Imaging of the Brain | completed | N/A | 17 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Sep 9, 2022 | clinicaltrials |
| NCT04410315 | Hyperlactatemia During and After Tumorcraniotomy | completed | — | 450 | Rigshospitalet, DenmarkOTHER | 1 | Aug 17, 2022 | clinicaltrials |
| NCT03762343 | Ultrasound-guided Greater Occipital Nerve Block in Children Undergoing Posterior Fossa Craniotomy | completed | Phase 3 | 40 | Kasr El Aini HospitalOTHER | 1 | Aug 15, 2022 | clinicaltrials |
| NCT02302235 | Ketogenic Diet Treatment Adjunctive to Radiation and Chemotherapy in Glioblastoma Multiforme: a Pilot Study(GBMXRT) | completed | Phase 2 | 42 | Mid-Atlantic Epilepsy and Sleep Center, LLCOTHER | 1 | Aug 11, 2022 | clinicaltrials |
| NCT00978562 | DSC-MRI With Ferumoxytol and DCE-MRI With Gadolinium in Imaging Vascular Properties in Younger Patients With Brain Tumors | completed | Early Phase 1 | 14 | OHSU Knight Cancer InstituteOTHER | 1 | Aug 3, 2022 | clinicaltrials |
| NCT03624114 | Prediction of Sphenoid Septation in MRI Compared With CT and Intraoperative Findings During Endoscopic Pituitary Adenoma Surgery(Scope) | completed | — | 40 | University Hospital, Basel, SwitzerlandOTHER | 2 | Aug 3, 2022 | clinicaltrials |
| NCT01609790 | Bevacizumab With or Without Trebananib in Treating Patients With Recurrent Brain Tumors | completed | Phase 2 | 137 | National Cancer Institute (NCI)NIH | 2 | Jul 21, 2022 | clinicaltrials |
| NCT02885272 | FDG PET Imaging in Diagnosing Patients With Glioblastoma | completed | Early Phase 1 | 21 | M.D. Anderson Cancer CenterOTHER | 1 | Jul 21, 2022 | clinicaltrials |
| NCT04148534 | Compare the Operating Condition of Two Levels of Muscle Relaxation on Facial Nerve MEP Monitoring in CPA Surgery | completed | N/A | 40 | Muhammad Magdy GaberOTHER | 1 | Jun 29, 2022 | clinicaltrials |
| NCT02644291 | Phase I Study of Mebendazole Therapy for Recurrent/Progressive Pediatric Brain Tumors | completed | Phase 1 | 16 | Sidney Kimmel Comprehensive Cancer Center at Johns HopkinsOTHER | 1 | Jun 23, 2022 | clinicaltrials |
| NCT02881957 | Hypovitaminosis D in Neurocritical Patients | completed | Phase 2 / Phase 3 | 274 | University of UtahOTHER | 1 | Jun 15, 2022 | clinicaltrials |
| NCT04302857 | Tractography Pilot Study Leipzig | completed | — | 20 | Tim WendeOTHER | 1 | Jun 10, 2022 | clinicaltrials |
| NCT04369703 | Copeptin as a Biomarker for Central Diabetes Insipidus Development Following Pituitary Surgery | completed | — | 199 | Mayo ClinicOTHER | 1 | Jun 3, 2022 | clinicaltrials |
| NCT01434602 | Phase I-II Everolimus and Sorafenib in Recurrent High-Grade Gliomas | completed | Phase 1 / Phase 2 | 86 | National Cancer Institute (NCI)NIH | 1 | Jun 1, 2022 | clinicaltrials |
| NCT02886572 | SIMT Stereotactic Radiosurgery Outcomes Study(SIMT) | completed | N/A | 40 | Duke UniversityOTHER | 1 | Jun 1, 2022 | clinicaltrials |
| NCT04055688 | Novel Exoscope System for 5-ALA Fluorescence-Guided Surgery for Gliomas | completed | — | 20 | H. Lee Moffitt Cancer Center and Research InstituteOTHER | 1 | May 31, 2022 | clinicaltrials |
| NCT02808416 | Personalized Cellular Vaccine for Brain Metastases (PERCELLVAC3)(PerCellVac3) | completed | Phase 1 | 10 | Guangdong 999 Brain HospitalOTHER | 1 | May 27, 2022 | clinicaltrials |
Data updated 23 days agoSource updated Mar 1, 2023source: clinicaltrials